1Aducanumab, the first Alzheimer's disease therapeutic drug targeting amyloid betaZHANG Fang, LIU Jie, SUN Tao-hua, CHEN An-jin, SHI Jie929-9322The visible particles or insoluble particles in antibody drug formulationsJIA Dong-chen, HE Wu933-9363The control strategy of starting materials used in solid-phase peptide synthesisWU Yi-fan, LIU Fu-li937-9414Prediction of the disintegration time limit of olanzapine orally disintegrating tablets based on the physical fingerprint of crospovidone and its critical quality attributesWANG Jue, HU Li, YANG Rui, SUN Hui-min942-9495The stability of group A&C meningococcal and Haemophilus influenzae type b ( conjugate) combined vaccineMU Shan-shan, WANG Zhen-ye, JIANG Zhi-yi, CHEN Zhong-wei, LIU Xiao-lei, SUN Shu-xue950-9546A review on the application of electrohydrodynamic technology in nano drug loading systemSUN Chu-jun, LI Meng-hao, LIU Lei, WANG Xiao-hui, DU Qing955-9647Progress in application of electrospray technology in preparation of microparticlesLI Yuan-qing, ZHAO Feng, MA Yin-ling, LIU Hong-xing, YIN Dian-shu965-9718Implementation and management of drug clinical trials during the period of COVID-19 epidemicLU Ming-ying, LIU Yu, LIU Qing-yue, YI Qiu-yue, ZHANG Cai-xia, LIU Xia, ZHANG Ya-ni972-9779Practice and reflection on the informatization of ethics reviewWANG Hui, WU Da-wei, YAN Zhao, TANG Qi-yu, LI Zi-wei, LI Ya-nan, XU Zhen-gang, TANG Yu, LI Ning978-98210Management of bioequivalence trials for orally inhaled and nasal drug productsWANG Xiao-qian, LIU Hong-jiao, LIU Chuan, CHEN Xi-jing983-99011Screening of antiplatelet aggregation quality markers of Salvia trijuga based on chemometrics and bioactivityLI Xie, ZHANG Feng-qin, LI Yang, ZHANG Hai-zhu, YU Li, ZHANG Yan-ru991-99712Investigation of intestinal absorption of echinocystic acid by single pass intestinal perfusion model in ratsLIU Wan-xia, CHEN Rui, BAN Yu-juan, TANG Lei, HUANG Jia-yu998-100213Tricholoma matsutake peptides protects from doxorubicin-induced cardiotoxicity through AMPK/Sirt1/PGC1ɑ pathwaysYE Ting, LI Meng-jiao, ZHANG Yu-kun, LU Qi, ZOU Lin-feng, GAO Yuan-zhen, ZHONG Ying-jie, SUN Wen-she, LIANG Bing, YUAN Yang, XING Dong-ming1003-101214The protective effect of Dl-3-n-butylphthalide on myelin sheath of corpus callosum in rats with vascular dementiaLI Mei-xi, GAO Ya-ran, NIU Xiao-li, CHENG Si-qi, WANG Tian-jun, ZHAO Jing-ru, LV Pei-yuan1013-101815Aflibercept for the treatment of neovascular age-related macular degeneration: a rapid health technology assessmentZHOU Peng-xiang, WANG En-te, LI Xiao-fei, ZHAI Suo-di1019-102616Literature analysis of adverse drug reactions induced by IL-17 A inhibitors:secukinumab and ixekizumabYANG Xiao-jiao, ZHOU Jin, DONG Yan, ZHAO Zhen-yu1027-1032 